R
  • 773.714.0705
  • Home
  • About Us
  • Specialty
    • Allergy/Immunology (7)
    • Cardiology (10)
    • Critical/Intensive Care (5)
    • Dentistry (2)
    • Dermatology (5)
    • Emergency Medicine (17)
    • Endocrinology (6)
    • ENT/Otolaryngology (1)
    • Family/General Practice (42)
    • Gastroenterology (8)
    • Geriatrics (17)
    • Hematology (14)
    • Hospital Medicine (21)
    • Infectious Disease (6)
    • Internal Medicine (43)
    • Nephrology (3)
    • Neurology (13)
    • Nutrition (2)
    • Obesity Medicine (1)
    • Obstetrics and Gynecology (11)
    • Oncology (20)
    • Ophthalmology (2)
    • Optometry (1)
    • Orthopedics (4)
    • Pain Management (1)
    • Pathology (14)
    • Pediatrics (12)
    • Pharmacy (27)
    • Physiatrists/Rehab Medicine (5)
    • Psychiatry (7)
    • Pulmonology (14)
    • Radiology (9)
    • Respiratory Therapy (4)
    • Rheumatology (4)
    • Sleep Medicine (2)
    • Surgery (15)
    • Urgent Care (2)
    • Urology (3)
  • Activities
    • Live
    • Online
  • Outcomes & Toolkits
New User? Login

Building Interprofessional Care Solutions in Rural Practice to Improve Screening and Mitigate Diagnosis and Treatment Delays in Patients with Alcohol Use Disorder (AUD)

SHARE WITH COLLEAGUE

Activity URL:

https://www.achlcme.org/detail/5818/Building-Interprofessional-Care-Solutions-in-Rural-Prac...

Click the "Start Activity" button to indicate you have reviewed the CME/CE information for this activity.

Start Activity
Building-Interprofessional-Care-Solutions-in-Rural-Practice-to-Improve-Screening-and-Mitigate-Diagnosis-and-Treatment-Delays-in-Patients-with-Alcohol-Use-Disorder-(AUD)
Format
Interactive Practice Guide
Time to Complete
2.50 hr(s).
Release Date
November 20, 2026
Expires On
November 20, 2027

Nearly 28 million people in the US met criteria for alcohol use disorder (AUD) last year, yet unhealthy alcohol use is routinely missed due to lack of routine screening. Even when screening does happen, the trail often goes cold from there: among patients with severe AUD, only a small fraction report being told about treatment options. Clinicians cite discomfort raising the topic, limited familiarity with screening guidelines, and no reliable process for turning a positive screen into next steps. Patients, for their part, often stay quiet, shaped by stigma, a belief the problem will resolve on its own, or simply not knowing treatment exists.

Rural settings face this gap from a steeper starting point. Provider shortages, long distances to specialty care, lack of behavioral health integration, and inconsistent broadband for telehealth all stand between a patient and the screening, brief intervention, and referral to treatment pathway that guidelines call for.

This education offers a focused way to build knowledge and skills for unhealthy alcohol use screening and diagnosis across clinical settings, including the implementation of SBIRT protocols suited to rural settings. It includes a mix of education and resources that can be tailored to the nuanced needs of diverse practices and help build infrastructures for ongoing dissemination and application of new knowledge to improve recognition of unhealthy alcohol use.

This activity is intended for primary care clinicians, emergency medicine clinicians, psychiatrists, social workers, addiction specialists, pharmacists, advanced practice providers, nurses, and other multidisciplinary team members.

Upon completion of this activity, learners will be able to:

  • Implement validated screening tools for detection of alcohol use disorder across healthcare settings to mitigate delays in diagnosis and treatment
  • Adopt culturally competent Brief Intervention strategies and tools to build motivation and direct patients to specialized addiction treatment
  • Develop continued clinical staff training programs to ensure confidence and competency with initiating Screening, Brief Intervention, and Referral to Treatment in routine clinical practice
  • Establish interprofessional, integrated care models to increase and improve access to patient-centric alcohol-related care in rural areas

Epidemiology of Unhealthy Alcohol Use and Alcohol Use Disorder

  • Spectrum of unhealthy alcohol use
  • Societal and economic burdens
  • Short- and long-term health risks

Screening and Diagnosis of AUD Across Practice Settings

  • Screening recommendations
  • Available screening tools
  • DSM-5 criteria for AUD

Patient-Centered Interprofessional Care Models in AUD

  • SBIRT
  • Motivational interviewing
  • Multidisciplinary team care strategies

Available and Emerging Medications for AUD

  • Guidelines for AUD treatment
  • Available medications for AUD: mechanisms of action and dosing
  • Emerging agents
  • Clinical trial data with GLP-1 RA-based therapy

Establishing Protocols and Clinical Pathways With SBIRT in Rural Settings

  • Engaging patients in shared decision-making
  • Referral strategies
  • Reimbursement for alcohol misuse screening

Provided by the Academy for Continued Healthcare Learning (ACHL) and the National Rural Health Resource Center.

Supported by an educational grant from Lilly.

Carolyn A. Chan, MD, MHS-MedEd (Chair)
Associate Professor of Medicine, Psychiatry and Internal Medicine
University of Cincinnati
Cincinnati, OH

Andrea Weber, MD, MME, FACP, FASAM, FAMP
Clinical Associate Professor, Psychiatry and Internal Medicine
University of Iowa Health Care
Iowa City, IA

The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships within 24 months (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with all ineligible companies. All relevant financial relationships have been mitigated prior to this activity. 

The following financial relationships have been provided:

Carolyn A. Chan, MD, MHS-MedEd – Nothing to disclose
Andrea Weber, MD, MME, FACP, FASAM, FAMP – Nothing to disclose

ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

This activity is being presented without bias and with commercial support.

The content for this activity was developed independently of any ineligible company. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor(s).

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.

This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Clinicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion. 

Discussion of scientific information on unapproved uses (SIUU), off-label, investigational, or experimental drug/device use: medications under development for the treatment of AUD.

This activity will take approximately 150 minutes to complete. To receive credit, learners are required to complete the pretest, view the online activity, and complete the posttest and evaluation. To receive credit, 66% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.

Partial credit may not be awarded for CPE credit; participation in the complete activity is required to receive credit. CPE credit will be submitted to CPE Monitor® on the first business day of each month.

Jointly Accredited Provider

The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician assistants, nurse practitioners, and nurses may participate in this educational activity and earn a certificate of completion as AAPA, AANP, and ANCC accept AMA PRA Category 1 Credits™ through their reciprocity agreements.

Jointly Accredited Provider

The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 

This activity has been approved for 2.5 contact hours.

ACPE Universal Activity Number: 0396-0000-26-030-H99-P
Activity Type: Knowledge
Release Date: November 20, 2026
Expiration Date: November 20, 2027

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

By providing your ABIM Diplomate number, you consent to have ACHL and/or our educational partners submit your participation in this activity to the ABIM through the ACCME PARS system. ABIM credit will be submitted to PARS on the first day of each month.

Nora Eldasher
neldasher@achlcme.org
Related Activities
Supporting Real-World Achievement of Treat-to-Target in IBD: Scalable Strategies for Integrating Objective Markers of Inflammation and Patient-Reported Monitoring in Routine Clinical Practice
Supporting Real-World Achievement of Treat-to-Target in IBD: Scalable Strategies for Integrating Objective Markers of Inflammation and Patient-Reported Monitoring in Routine Clinical Practice
How Should I Treat AChR-Ab Seronegative gMG? Weighing The Latest Evidence to Inform Precision-Based Care
How Should I Treat AChR-Ab Seronegative gMG? Weighing The Latest Evidence to Inform Precision-Based Care
Unlocking the Therapeutic Potential of Amylin-Based Therapies for Obesity
Unlocking the Therapeutic Potential of Amylin-Based Therapies for Obesity
View All Activities

You are being redirected to another site.


ACHL - Academy for Continued Healthcare Learning

308 S. Jefferson St.,
Suite 312,
Chicago, IL 60661

  • Phone: 773.714.0705
  • Fax: 773.714.0707
  • Home
  • Specialty
  • Sitemap
  • Privacy Policy
  • Contact Us
  • Follow us on Twitter
  • Like us on Facebook
  • Follow us on LinkedIn

Copyright © 2026 Academy for Continued Healthcare Learning. All Rights Reserved.